From Name:
From Email:
To Name:
To Email:

Optional Message:


Tamoxifen reduced contralateral breast cancer risk in patients with BRCA mutations

from HemOnc Today

Women with BRCA1 or BRCA2 mutations who underwent adjuvant tamoxifen treatment for breast cancer were at reduced risk for contralateral disease, according to results of a pooled observational analysis. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063